Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:12 AM
Ignite Modification Date:
2025-12-25 @ 12:12 AM
NCT ID:
NCT02842658
Eligibility Criteria:
Inclusion Criteria:
* Subjects must be able to communicate meaningfully with the investigator and must be legally competent to provide written informed consent
* Subjects will have been recently diagnosed with breast cancer (stage I, II or III)
* Subjects must be scheduled by their oncologist to undergo anthracycline based chemotherapy (doxorubicin and cyclophosphamide) in the neoadjuvant/adjuvant setting
Exclusion Criteria:
* Unstable angina
* Myocardial infarction in the past 4 weeks
* Uncompensated heart failure
* New York Heart Association class IV symptoms
* Complex ventricular arrhythmias
* Medical orthopedic conditions precluding stationary cycling
* Medical conditions precluding neuropsychological assessment
* Symptomatic severe aortic stenosis
* Acute pulmonary embolus
* Acute myocarditis
* Untreated high-risk proliferative retinopathy
* Recent retinal hemorrhage
* Uncontrolled hypertension
* Sodium and/or Potassium ≥ Grade 2
* Pregnant Women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
70 Years
Study:
NCT02842658
Study Brief:
Protocol Section:
NCT02842658